Abdelwahab, W.M.; Auclair, S.; Borgogna, T.; Siram, K.; Riffey, A.; Bazin, H.G.; Cottam, H.B.; Hayashi, T.; Evans, J.T.; Burkhart, D.J.
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics 2024, 16, 107.
https://doi.org/10.3390/pharmaceutics16010107
AMA Style
Abdelwahab WM, Auclair S, Borgogna T, Siram K, Riffey A, Bazin HG, Cottam HB, Hayashi T, Evans JT, Burkhart DJ.
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics. 2024; 16(1):107.
https://doi.org/10.3390/pharmaceutics16010107
Chicago/Turabian Style
Abdelwahab, Walid M., Sarah Auclair, Timothy Borgogna, Karthik Siram, Alexander Riffey, Hélène G. Bazin, Howard B. Cottam, Tomoko Hayashi, Jay T. Evans, and David J. Burkhart.
2024. "Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses" Pharmaceutics 16, no. 1: 107.
https://doi.org/10.3390/pharmaceutics16010107
APA Style
Abdelwahab, W. M., Auclair, S., Borgogna, T., Siram, K., Riffey, A., Bazin, H. G., Cottam, H. B., Hayashi, T., Evans, J. T., & Burkhart, D. J.
(2024). Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses. Pharmaceutics, 16(1), 107.
https://doi.org/10.3390/pharmaceutics16010107
